Srikanth K. Reddy

Srikanth K. Reddy is a partner in Goodwin Procter's IP Litigation practice, concentrating on a diverse range of intellectual property litigation, including patent, trademark, copyright, and trade secret matters. He is a key member of the firm's Life Sciences Disputes group, bringing substantial experience in Hatch-Waxman/ANDA cases, U.S. International Trade Commission (ITC) Section 337 investigations, and district court patent litigation. His technological proficiency spans various fields, including life sciences, generic pharmaceuticals, chemical processing of LEDs, razor cartridge connectors, and source code analysis. While the provided data tracks a defendant-side appearance, his broader experience demonstrates representation for both patent owners and defendants, notably defending generic pharmaceutical companies.

Based in Goodwin Procter's Boston office, Mr. Reddy was elected partner at the firm in October 2015. His notable case work includes representing OSRAM in patent infringement proceedings related to LED technology and successfully representing a patent owner in a jury trial concerning source code analysis. A significant achievement includes securing a trial victory for Dr. Reddy's Laboratories, where a U.S. District Judge found non-infringement in a patent case brought by Indivior Inc. and MonoSol Rx involving the opioid addiction treatment drug Suboxone®, which led to a notable increase in Dr. Reddy's stock value.

Mr. Reddy possesses extensive experience with post-grant proceedings before the Patent Trial and Appeal Board (PTAB). He has been involved in parallel IPR proceedings alongside district court litigation, as seen in the OSRAM matter, and served as lead counsel for Dr. Reddy's Laboratories in an IPR related to the Suboxone® patent. He also acted as counsel for Samsung in a separate IPR proceeding. He earned his J.D. from Northwestern University School of Law and is a member of the Boston Bar Association.